2016 VAM: 3305 - Severe Asthma in Children: From Mechanisms to Disease Modification

Frequent exacerbations are an important feature and associated with significant morbidity, health care utilization and costs.Furthermore, recurrent severe exacerbations may lead to progressive loss of lung function and increased asthma severity over time.Recent studies have helped elucidate mechanisms underlying severe asthma in children. With the emergence of biologic therapies, there has been interest in their role in the prevention of asthma exacerbations and potential utility for disease modification.

AMA PRA Category 1 Credits™: 1.25
CE: 1.25

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants will be able to:
1.  Describe the frequency and common features of severe asthma in children
2.  Identify common underlying mechanisms of severe asthma in children
3.  Discuss the efficacy of omalizumab and the potential for disease modification in children
 

 

Additional Information

AttachmentSize
PDF icon 2016 Annual Meeting Disclosures120.13 KB
Summary
Available credit: 
  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.
Course opens: 
05/31/2016
Course expires: 
05/31/2018
Cost:
$15.00
Rating: 
0

Leonard B. Bacharier, MD FAAAAI, Washington University School of Medicine and St. Louis Children, Saint Louis, MO

Dr. Theresa W. Guilbert, MD MS, Cincinnati Children's Hospital & Medical Center, Cincinnati, OH

Dr. Daniel J. Jackson, MD, Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI

 

Available Credit

  • 1.25 Attendance
    Attendance credit.
  • 1.25 CE
    CE credit.
  • 1.25 CME
    CME credit.

Price

Cost:
$15.00
Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.